The unstoppable John Fauber of the Milwaukee Journal-Sentinel has done another investigative piece in a long series, this time indicting researchers hired by Medtronic, who, Fauber reports, failed to disclose a potential cancer risk associated with a bone-growth agent in Medtronic’s spine-surgery produce, Infuse.
The Journal-Sentinel asked independent experts to review the research, and Fauber reports that they found problems with the way the researchers reported the cancer findings. Further, Fauber unearthed 1,000 pages of FDA documents in which the cancer question was discussed.
Fauber’s stories are, as I think I’ve said before, textbook examples of investigative science reporting. Indeed, I think I’m going to use of few of them in my science journalism class.
And if you or anyone in your family needs spine surgery, read Fauber’s archives first.
– Paul Raeburn
Leave a Reply